NIPT or amniocentesis: understanding your results

What does NIPT actually test for?

NIPT (noninvasive prenatal testing) checks tiny bits of DNA from the placenta that float in your blood. This works because placental DNA is almost always identical to your baby's DNA. So a simple blood draw from you can offer a window into your baby's genes, according to MedlinePlus Genetics.

One nice thing about NIPT is timing. Per the Cleveland Clinic, you can have it done starting at 10 weeks of pregnancy, and any time after that up until delivery. There's no single narrow window you have to catch.

But hold onto one word: screening. NIPT estimates risk based on the DNA fragments it finds. It doesn't examine your baby's cells directly, the way a diagnostic test does. That difference is the key to everything else in this article.

How accurate is NIPT, really?

NIPT is a strong screening tool. The Cleveland Clinic reports it catches about 99% of Down syndrome cases and about 97% to 98% of trisomy 18 cases. It also produces fewer false positives overall than other prenatal screens, like the quad screen.

Those numbers are reassuring, but no screening test is perfect. MedlinePlus Genetics notes NIPT can give a false positive — flagging increased risk when your baby is actually fine — or a false negative, showing decreased risk when a condition is actually present. In other words, a high-risk result doesn't confirm a condition. And a low-risk result doesn't rule one out.

Why isn't a high-risk screen a diagnosis?

This is where many parents feel the ground shift, so here it is plainly: a high-risk NIPT result should be followed by diagnostic testing. That confirms the finding before a genetic condition is considered established, according to MedlinePlus Genetics.

That next step exists because screening tests are built to flag possibility, not certainty. Diagnostic testing — amniocentesis — closes that gap. It examines your baby's cells directly, instead of estimating risk from DNA fragments in your blood.

What can amniocentesis tell you?

Amniocentesis means collecting a small sample of the fluid around your baby (amniotic fluid). That fluid contains your baby's cells, which can be checked directly. Because it examines actual cells instead of estimating probability, it counts as a diagnostic test. The Cleveland Clinic puts its accuracy at about 99%.

Even so, a diagnosis isn't the whole picture. The Cleveland Clinic notes amniocentesis can confirm a condition is present without saying how severe it will be. Keep that in mind for any follow-up talk with your provider or a genetic counselor. Confirmation is the start of understanding, not the end of it.

What's normal after amniocentesis, and when should you call the doctor?

Choosing a diagnostic test after a high-risk screen deserves full information about the procedure. Amniocentesis carries a small risk of miscarriage — about 1 in 1,000 cases, per the Cleveland Clinic. Minor spotting or cramping afterward is more common, and usually nothing to worry about. It affects roughly 1 to 2 in 100 women.

Beyond that mild, expected discomfort, some symptoms need a call to your provider without delay. Contact your healthcare provider right away if, after amniocentesis, you have: fever or chills; vaginal bleeding beyond light spotting; vaginal discharge or leaking fluid; belly pain that's worse than mild cramps; or swelling or redness where the needle went in. Call as soon as you notice these — don't wait for your next scheduled visit.

How do these two tests work together?

Think of NIPT and amniocentesis as two different tools, not competitors. NIPT is a highly sensitive way to flag risk early, without any procedure on your body. Amniocentesis is the direct, diagnostic confirmation that follows when a screen suggests something worth a closer look. Neither test's numbers exist to scare you. They exist so you and your provider can make an informed next move together.

If you're sitting with a high-risk NIPT result right now, the most useful next step is usually the same: talk with your obstetric provider or a genetic counselor. Ask whether diagnostic testing makes sense for your result, your timeline, and how you feel about the small procedural risks. You don't have to interpret any of these numbers alone.

Frequently asked questions

Sources

1. NIPT works by analyzing cell-free DNA (cfDNA) fragments from the placenta that circulate in a pregnant woman's bloodstream, which is possible because placental DNA is usually identical to fetal DNA. — MedlinePlus Genetics
2. NIPT is a screening test, not a diagnostic one, and it can produce both false positive results (indicating increased risk when the fetus is unaffected) and false negative results (indicating decreased risk when the fetus is actually affected). — MedlinePlus Genetics
3. A positive (high-risk) NIPT result should be followed by diagnostic testing to confirm the finding before a genetic condition is considered established. — MedlinePlus Genetics
4. NIPT detects about 99% of Down syndrome cases and about 97% to 98% of trisomy 18 cases, and overall produces fewer false positives than other prenatal screening methods like the quad screen. — Cleveland Clinic
5. NIPT can be performed starting at 10 weeks of pregnancy and any time up until delivery. — Cleveland Clinic
6. Amniocentesis carries a small risk of miscarriage, occurring in about 1 in 1,000 cases, while minor spotting or cramping afterward is more common, affecting about 1 to 2 in 100 women. — Cleveland Clinic
7. Amniocentesis is about 99% accurate as a diagnostic test, though it can confirm the presence of a condition without indicating how severe that condition will be. — Cleveland Clinic
8. After amniocentesis, warning signs that require calling a healthcare provider include fever or chills, vaginal bleeding beyond light spotting, vaginal discharge or leaking fluid, moderate to severe abdominal pain worse than mild cramps, and swelling or redness at the needle insertion site. — Cleveland Clinic